The Cardioprotective Effect of Mildronate is Diminished After Co-Treatment With l-Carnitine

Journal of Cardiovascular Pharmacology and Therapeutics - Tập 17 Số 2 - Trang 215-222 - 2012
Janis Kuka1, Reinis Vilšķe̅rsts1,2, Helena Cirule1, Marina Makrecka‐Kuka1,2, Osvalds Pugovičs1, Ivars Kalvinsh1, Maija Dambrova1,2, E. Liepinsh1
1Latvian Institute of Organic Synthesis, Riga, Latvia
2Rigas Stradins University, Riga, Latvia

Tóm tắt

Mildronate, an inhibitor of l-carnitine biosynthesis and uptake, is a cardioprotective drug whose mechanism of action is thought to rely on the changes in concentration of l-carnitine in heart tissue. In the present study, we compared the cardioprotective effect of mildronate (100 mg/kg) and a combination of mildronate and l-carnitine (100 + 100 mg/kg) administered for 14 days with respect to the observed changes in l-carnitine level and carnitine palmitoyltransferase I (CPT-I)-dependent fatty acid metabolism in the heart tissues. Concentrations of l-carnitine and its precursor γ-butyrobetaine (GBB) were measured by ultraperformance liquid chromatography with tandem mass spectrometry. In addition, mitochondrial respiration, activity of CPT-I, and expression of CPT-IA/B messenger RNA (mRNA) were measured. Isolated rat hearts were subjected to ischemia–reperfusion injury. Administration of mildronate induced a 69% decrease in l-carnitine concentration and a 6-fold increase in GBB concentration in the heart tissue as well as a 27% decrease in CPT-I-dependent mitochondrial respiration on palmitoyl-coenzyme A. In addition, mildronate treatment induced a significant reduction in infarct size and also diminished the ischemia-induced respiration stimulation by exogenous cytochrome c. Treatment with a combination had no significant impact on l-carnitine concentration, CPT-I-dependent mitochondrial respiration, and infarct size. Our results demonstrated that the mildronate-induced decrease in l-carnitine concentration, concomitant decrease in fatty acid transport, and maintenance of the intactness of outer mitochondrial membrane in heart mitochondria are the key mechanisms of action for the anti-infarction activity of mildronate.

Từ khóa


Tài liệu tham khảo

10.1113/jphysiol.2006.125799

10.1016/j.addr.2009.04.024

10.1016/S1050-1738(02)00175-5

10.1016/0006-2952(88)90717-4

10.1046/j.1432-1327.2001.02065.x

10.1016/j.lfs.2008.08.008

10.1097/01.fjc.0000250077.07702.23

Sesti C, 2006, J Cardiovasc Pharmacol, 47, 493, 10.1097/01.fjc.0000211732.76668.d2

10.1111/j.1476-5381.2009.00319.x

10.1159/000210015

10.1016/S1734-1140(11)70587-4

10.1196/annals.1320.002

10.1007/s10540-005-2897-2

10.1016/j.physbeh.2008.06.012

10.1016/S0024-3205(01)01067-0

10.1111/j.1742-7843.2009.00461.x

10.1016/j.cmet.2007.03.002

10.1074/jbc.270.12.6949

10.3109/14756360902829527

10.1007/s10863-010-9275-x

10.3891/acta.chem.scand.17s-0129

10.1038/sj.cdd.4402035

Bernatoniene J, 2011, Phytother Res, 1054, 25(7)

10.1111/j.1472-8206.1998.tb00936.x

10.1023/A:1007093926315

10.1021/bi00321a022

10.1023/B:MCBI.0000012853.20116.06

10.1074/jbc.M611391200

10.1161/CIRCULATIONAHA.106.642009

10.1586/14779072.5.6.1123

10.1152/ajpheart.00599.2005

10.1007/s00395-009-0003-9

10.1002/ajmg.c.30087

Liepinsh E, J Pharm Pharmacol

Thông tin
Thông tin xuất bản

Journal of Cardiovascular Pharmacology and Therapeutics

Tập 17 Số 2

215-222

Thông tin tác giả